First-of-its-kind, non-invasive continuous glucose monitor (CGM) was designed leveraging Phillips-Medisize extensive medical device design and development expertise

首次使用Phillips Medisize广泛的医疗设备设计和开发专业知识设计了无创连续血糖监测仪（CGM）

Phillips-Medisize's proven experience in human-centered product design, electronics, connectivity, software, manufacturability and regulatory compliance will drive commercialization

Phillips Medisize在以人为本的产品设计，电子，连接，软件，可制造性和法规遵从方面的经验将推动商业化

HUDSON, Wis., Oct. 3, 2023 /PRNewswire/ -- Phillips-Medisize, a Molex company, and a leader in the design, engineering and manufacturing of pharmaceutical drug delivery, invitro diagnostic and medtech devices, has teamed with GlucoModicum, an innovative medtech company based in Finland, to design and eventually commercialize a proprietary non-invasive, wearable device that removes technology and patient-care roadblocks to continuous glucose monitoring (CGM)..

威斯康星州哈德逊市，2023年10月3日/PRNewswire/-Molex公司的Phillips Medisize，以及药物输送，invitro诊断和medtech设备设计，工程和制造领域的领导者，已与GlucoModicum合作，一家总部设在芬兰的创新medtech公司，旨在设计并最终商业化专有的非侵入性，可穿戴设备，消除连续血糖监测（CGM）的技术和患者护理障碍。。

Continue Reading

继续阅读

Phillips-Medisize and GlucoModicum team up to deliver a first-of-its-kind, needle-free continuous glucose monitoring device (CGM) that removes patient-care roadblocks by leveraging magnetohydrodynamic (MHD) technology for non-invasive glucose monitoring.

Phillips Medisize和GlucoModicum团队通过利用磁流体动力学（MHD）技术进行无创血糖监测，提供首款无针连续血糖监测装置（CGM），消除患者护理障碍。

'We wanted to create a solution that is needle free, accurate and more affordable so people would better monitor their glucose,' said Jokke Mäki, managing director of GlucoModicum. 'Working with Phillips-Medisize, we applied compelling science to develop a world-class product that may help billions of people better manage their diabetes.'.

“我们希望创建一种无针，准确且更实惠的解决方案，以便人们更好地监测他们的葡萄糖，”GlucoModicum总经理JokkeMäki说与Phillips Medisize合作，我们应用引人注目的科学开发了一种世界级产品，可以帮助数十亿人更好地管理他们的糖尿病。

Accelerating the Product Innovation Journey In seeking a more convenient, rapid and gentle CGM alternative, GlucoModicum discovered that magnetohydrodynamic (MHD) technology could be used to apply a small amount of energy directly to interstitial fluid—the body fluid between blood vessels and cells—to drive it to the surface of the skin for quick and easy extraction of a glucose sample. .

加速产品创新历程在寻求更方便，快速和温和的CGM替代品时，GlucoModicum发现磁流体动力学（MHD）技术可用于将少量能量直接应用于组织液-血管和细胞之间的体液-以驱动它到皮肤表面，以快速简便地提取葡萄糖样品。 .

While their scientists conducted rigorous research, GlucoModicum sought an experienced contract development and manufacturing organization (CDMO) to assist in realizing their vision for a new device, called Talisman. This device is designed to adhere to a patient's arm, and integrates the MHD technology, ultra-sensitive biosensors and advanced algorithms while connecting to a smartphone app for data collection and reporting.

在他们的科学家进行严格研究的同时，GlucoModicum寻求经验丰富的合同开发和制造组织（CDMO）来协助实现他们对名为Talisman的新设备的愿景。该设备旨在粘附患者的手臂，并集成MHD技术，超灵敏生物传感器和先进算法，同时连接到智能手机应用程序进行数据收集和报告。

The device is not yet FDA approved and does not have the CE mark. In developing the Talisman, Phillips-Medisize applied special expertise in industrial design, mechanical and electrical engineering, connectivity, material science, miniaturization, supply chain management, software development, manufacturing, testing, quality assurance and regulatory compliance.'We started with ideas, concepts and drawings,' said Homer Fairley, business development manager for Phillips-Medisize.

该设备尚未获得FDA批准，也没有CE标志。在开发Talisman时，Phillips Medisize在工业设计，机械和电气工程，连通性，材料科学，小型化，供应链管理，软件开发，制造，测试，质量保证和法规遵从方面应用了专业知识Phillips Medisize业务开发经理Homer Fairley说，我们从想法，概念和图纸开始。

'The day we provided the finished sample product to GlucoModicum was a moment of celebration for both parties, as it really brought the possibilities to life. Now that there is a proven concept, we look forward to the opportunity to leverage Phillips-Medisize's high-volume manufacturing capabilities to produce hundreds of millions of units on time and in a cost-effective manner.

“我们向GlucoModicum提供成品样品的那一天是双方庆祝的时刻，因为它确实为生活带来了可能性。现在已经有了一个成熟的概念，我们期待有机会利用Phillips Medisize的大批量生产能力，以经济高效的方式按时生产数亿台产品。

That's a big benefit to this project.'In November 2022, GlucoModicum published results of the safety, efficacy and effectiveness of its proprietary MHD technology in Scientific Reports, based on glucose tolerance tests conducted on five healthy volunteers. The results further supported previously published data that demonstrated GlucoModicum's MHD technology and biosensor solution was 13 times more effective than other needle-free approaches tested in extracting interstitial fluid from the skin.

这对这个项目有很大的好处。”2022年11月，GlucoModicum根据对五名健康志愿者进行的葡萄糖耐量试验，在科学报告中公布了其专有MHD技术的安全性，有效性和有效性结果。结果进一步支持了先前公布的数据，这些数据证明了GlucoModicum的MHD技术和生物传感器解决方案比从皮肤提取间质液中测试的其他无针方法有效13倍。

Addit.

附加。

GlucoModicum and Phillips-Medisize Case Study

GlucoModicum和Phillips Medisize案例研究

Phillips-Medisize Brings Possibilities to Life Phillips-Medisize, a Molex company, collaborates with leading pharmaceutical, medical technology and invitro diagnostic companies to design, engineer and manufacture life-saving innovations. In addition, the company's specialty commercial business supports automotive, consumer and defense industries.

Phillips Medisize为Life带来可能性Molex公司Phillips Medisize与领先的制药，医疗技术和invitro诊断公司合作设计，设计和制造挽救生命的创新。此外，该公司的专业商业业务支持汽车，消费者和国防行业。

A contract development and manufacturing organization (CDMO), Phillips-Medisize leverages its 60 years of expertise and globally renowned capabilities to collaborate with customers to deliver products and solutions that annually help millions of patients, healthcare professionals and individuals live healthier, more productive lives.

Phillips Medisize合同开发和制造组织（CDMO）利用其60年的专业知识和全球知名能力与客户合作，提供产品和解决方案，每年帮助数百万患者，医疗保健专业人员和个人过上更健康，更富有成效的生活。

About Molex Molex is a global electronics leader committed to making the world a better, more-connected place. With presence in more than 40 countries, Molex enables transformative technology innovation in the automotive, data center, industrial automation, healthcare, 5G, cloud and consumer device industries.

关于Molex Molex是全球电子领导者，致力于使世界变得更好，更连接。Molex拥有40多个国家，可在汽车，数据中心，工业自动化，医疗保健，5G，云和消费设备行业实现变革性技术创新。

Through trusted customer and industry relationships, unrivaled engineering expertise, and product quality and reliability, Molex realizes the infinite potential of Creating Connections for Life. For more information, visit www.molex.com.SOURCE Molex Incorporated.

通过可信的客户和行业关系，无与伦比的工程专业知识以及产品质量和可靠性，Molex实现了为生活建立联系的无限潜力。欲了解更多信息，请访问www.molex.com.SOURCE molex Incorporated。